P04-01. Simultaneous enumeration of HIV-1 gp41 Env-specific IgG and IgM antibody-secreting cells with a multiplex B-cell fluorospot assay

by Haynes BF, Moody MA, Vandergrift N, Hwang K, Bonsignori M
Published 2009-10-01

Affinity maturation pathway of an anti-MPER neutralizing mAb, CAP206-CH12

by Tumba NL, Gray ES, Lambson BE, Karim SS, Liao H, Haynes BF, Alam M, Morris L
Published 2012-09-01

Apoptotic microparticles generated during acute HIV-1 infection inhibit human dendritic cells via CD44

by Frleta D, Ochoa CE, Kramer HB, Khan SA, Stacey AR, Borrow P, Kessler BM, Haynes BF, Bhardwaj N
Published 2012-09-01

P04-44. Generation of antibody responses to HIV-1 membrane proximal external region (MPER) antigen

by Haynes BF, Liao H, Alam M, Moody MA, Verkoczy L, Liao D, Kuraoka M, Holl TM, Kelsoe GH
Published 2009-10-01

P20-17. Evolution of multiple transmitted viruses during the early stage of HIV-1 infection

by McMichael A, Goonetilleke N, Keele B, Pavlicek J, Chen S, Hopper J, Kirchherr JL, Haynes BF, Gao F
Published 2009-10-01

P04-26. Immunological tolerance prevents the expression of a broadly reactive neutralizing HIV-1 antibody

by Kelsoe G, Liao H, Alam SM, Ouyang Y, Bouton-Verville H, Holl TM, Diaz M, Verkoczy L, Haynes BF
Published 2009-10-01

V1/V2-directed antibodies elicited in RV144 vaccinees bind to a structurally polymorphic site

by McLellan JS, Gorman J, Bonsignori M, Hwang K, Liao H, Rerks-Ngarm S, Nitayaphan S, Michael NL, Kim JH, Haynes BF, Kwong PD
Published 2012-09-01

Detection of antibodies to the α4β7 integrin binding site on HIV-1 gp120 V2 loop using a novel cell adhesion assay

by Rao M, Karasavvas N, Pinter A, Liao H, Bonsignori M, Mathieson B, Zolla-Pazner S, Haynes BF, Michael NL, Kim JH, Alving CR, Peachman KK
Published 2012-09-01

Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein

by Alexander J, Gurwith M, Mendy J, Vang L, Manayani D, Avanzini J, Guenther B, Farness P, Haynes BF, Liao H, Montefiori DC, LaBranche CC, Mayall T
Published 2012-09-01

P04-54 LB. Genetic signature analysis identifies the CD4i region of gp120 as a determinant of broadly NAb responses in HIV-1-infected individuals

by Haynes BF, Seaman M, Gao H, Greene K, Tang H, Li M, Kumar A, Gao F, Lapedes A, Daniels M, Bhattacharya T, Gnanakaran G, Montefiori DC, Korber BT
Published 2009-10-01

A short segment in the HIV-1 gp120 V1/V2 region is a major determinant of neutralization resistance to PG9-like antibodies

by Doria-Rose NA, Georgiev I, Staupe RP, O'Dell S, Chuang G, Gorman J, McLellan JS, Pancera M, Bonsignori M, Haynes BF, Burton DR, Koff WC, Kwong PD, Mascola JR
Published 2012-09-01

Isolation of a clonal lineage of IgA broadly neutralizing antibodies from a chronically infected Tanzanian subject

by Moody M, Drinker MS, Gurley TC, Amos JD, Eudailey JA, Armand LC, Parks R, Gray ES, Morris L, Finzi A, Yang X, Sodroski J, Liao H, Tomaras GD, Montefiori DC, Haynes BF
Published 2012-09-01

Lack of IgA envelope-reactive antibody producing cells in terminal ileum in early and chronic HIV-1 infection

by Trama AM, Liao H, Foulger A, Marshall DJ, Whitesides JF, Parks R, Meyerhoff R, Lloyd KE, Donathan M, Lucas J, Soderberg K, Kepler TB, Vandergrift N, Yates N, Tomaras GD, Moody MA, Haynes BF
Published 2012-09-01

Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial preferentially use the VH1 gene family

by Bonsignori M, Pollara J, Moody MA, Kepler TB, Chen X, Gurley TC, Kozink DM, Marshall DJ, Whitesides JF, Kaewkungwal J, Nitayaphan S, Pitisuttithum P, Rerks-Ngarm S, Kim JH, Michael NL, Montefiori DC, Liao H, Ferrari G, Haynes BF
Published 2012-09-01

S021-04 OA. A large-scale analysis of immunoglobulin sequences derived from plasmablasts/plasma cells in acute HIV-1 infection subjects

by Markowitz M, Margolis DM, Shea TC, Kelsoe GH, Moody MA, Tomaras GD, Gao F, Yang Y, Marshalls DJ, Whitesides JF, Amos J, Parks R, Derosa K, Nagel A, Chen X, Dixon A, Liao H, Munshaw S, Goepfert P, Shaw G, Haynes BF, Kepler TB
Published 2009-10-01

Vaccine-induced ADCC-mediating antibodies target unique and overlapping envelope epitopes

by Pollara J, Bonsignori M, Moody M, Alam M, Liao H, Hwang K, Pickeral J, Kappes J, Ochsenbauer C, Soderberg K, Gurley TC, Kozink DM, Marshall DJ, Whitesides JF, Montefiori D, Robinson JE, Kaewkungwal J, Nitayaphan S, Pitisuttithum P, Rerks-Ngarm S, Kim J, Michael N, Tomaras G, Haynes BF, Ferrari G
Published 2012-09-01

Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial

by Williams WB, Jones K, Krambrink A, Grove D, Liu P, Yates NL, Moody MA, Ferrari G, Pollara J, Moodie Z, Morgan CA, Liao H, Montefiori DC, Ochsenbauer C, Kappes J, Hammer S, Mascola J, Koup R, Corey L, Nabel G, Gilbert P, Churchyard G, Keefer M, Graham BS, Haynes BF, Tomaras GD
Published 2012-09-01

Antibody lineages with evidence of somatic hypermutation persisting for >4 years in a South African subject with broad neutralizing activity

by Moody M, Trama AM, Bonsignori M, Tsao C, Drinker MS, Gurley TC, Amos JD, Eudailey JA, Armand LC, Parks R, Lloyd KE, Wang S, Seo K, Lee J, Jackson KJ, Hoh R, Pham T, Roskin KM, Boyd SD, Fire AZ, Gray ES, Morris L, Liao H, Tomaras GD, Kepler TB, Kelsoe G, Haynes BF
Published 2012-09-01

Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2

by Liao L, Bonsignori M, Hwang K, Moody AM, Park R, Crawford S, Chen H, Jeffries TL, Cooper M, Lu X, De R, Karasavvas N, Rerks-Ngarm S, Nitayaphan S, Kaewkungwal J, Tovanabutra S, Pitisuttithum P, Tartaglia J, Sinangil F, Kim J, Michael NL, Tomaras GD, Yang Z, Dai K, Pancera M, Nabel GJ, Mascola JR, Kwong PD, Pinter A, Zolla-Pazner S, Alam MS, Haynes BF
Published 2012-09-01

T-cell based sieve analysis ties HLA A*02 to vaccine efficacy and IgA-C1 immune correlate in RV144 Thai trial

by Hertz T, Gartland A, Janes H, Li S, Fong Y, Tomaras GD, Morris D, Geraghty D, Kijak GH, Edlefsen PT, Rolland M, Larsen BB, Tovanabutra S, Sanders-Buell E, DeCamp AC, Magaret CA, Ahmed H, Nariya S, Wong K, Zhao H, Deng W, Maust BS, Bose M, Howell S, Lazzaro M, Bates A, Lei E, Bradfield A, Ibitamuno G, Assawadarachai V, O'Connel RJ, deSouza MS, Nitayaphan S, Rerks-Ngarm S, Robb ML, McElrath MJ, Haynes BF, Michael NL, Gilbert PB, Mullins JI, Kim JH
Published 2012-09-01